Analyzing Healthcare

In this episode of Analyzing Healthcare by SCALE Community proudly supported by SCALE Healthcare x JPMorgan, we dive deep with John McDonough, professor at the Harvard T.H. Chan School of Public Health, to explore the growing public health crisis driven by federal research funding cuts. McDonough dissects the Harvard funding crisis, the erosion of grant-supported research institutions, and the challenges facing academic medical research under the Trump administration and beyond. We examine how shifts in healthcare policy research, NIH funding threats, and the impact of political funding decisions are reshaping public health, particularly in health disparities research, environmental health studies, and population health innovation. The conversation also contrasts the U.S. and European healthcare systems, highlights the limitations of value-based care, and emphasizes the importance of state-level healthcare policy experimentation in advancing more equitable, sustainable solutions.

Title: John McDonough on Population Health, Research Disruption & the Harvard Funding Crisis | Analyzing Healthcare | SCALE Community

Key Timestamps:

• (00:00) Introduction to Harvard T.H. Chan School of Public Health
• (03:00) The Role of Research in Public Health
• (06:10) Nutrition and Public Health Research
• (09:05) Population Health vs. Public Policy
• (11:56) Healthcare Spending and Health Outcomes
• (14:51) The Obesity Crisis in America
• (18:01) Environmental Health Determinants
• (22:54) EU vs. US Healthcare System: A Comparative View
• (27:06) Structural Challenges in the U.S. Healthcare System
• (31:58) Value-Based Care: Insights & Limitations
• (40:41) Why State-Level Policy Variations Matter

Key Takeaways:

• The academic funding crisis threatens long-term innovation in public health education and healthcare research.
• Nutrition research and environmental health studies remain critically underfunded.
• The U.S. prioritizes reactive care over preventive population health initiatives.
• Obesity and environmental factors drive poor health outcomes.
• State-level experimentation could be a catalyst for nationwide policy change.
• Despite challenges, opportunities exist to refocus research investment on health equity, health system innovation, and population-level outcomes.

⁠linkedin.com/in/john-mcdonough-2bb49825⁠

⁠linkedin.com/in/roy-bejarano-a5669ba8⁠

⁠www.scale-community.com ⁠

About the Guest:

John McDonough is a renowned health policy expert and Harvard professor whose work has shaped U.S. healthcare reform, including key roles in the Affordable Care Act. With decades of experience in government, academia, and advocacy, he brings unmatched insight into health systems, policy analysis, and public health—making him a leading voice in the national healthcare conversation.

Keywords

Harvard TH Chan, Public Health, Nutrition, Healthcare Policy, Population Health, Obesity, Environmental Health, Research Funding, Health Outcomes, Healthcare Spending, Healthcare Systems, Europe, US Healthcare, Value-Based Care, State Policy, Healthcare Outcomes, Investment, Patient Care, Medical Care, Population Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

In this episode of Analyzing Healthcare by SCALE Community proudly supported by SCALE Healthcare x JPMorgan, we dive deep with John McDonough, professor at the Harvard T.H. Chan School of Public Health, to explore the growing public health crisis driven by federal research funding cuts. McDonough dissects the Harvard funding crisis, the erosion of grant-supported research institutions, and the challenges facing academic medical research under the Trump administration and beyond. We examine how shifts in healthcare policy research, NIH funding threats, and the impact of political funding decisions are reshaping public health, particularly in health disparities research, environmental health studies, and population health innovation. The conversation also contrasts the U.S. and European healthcare systems, highlights the limitations of value-based care, and emphasizes the importance of state-level healthcare policy experimentation in advancing more equitable, sustainable solutions.

Title: John McDonough on Population Health, Research Disruption & the Harvard Funding Crisis | Analyzing Healthcare | SCALE Community

Key Timestamps:

• (00:00) Introduction to Harvard T.H. Chan School of Public Health
• (03:00) The Role of Research in Public Health
• (06:10) Nutrition and Public Health Research
• (09:05) Population Health vs. Public Policy
• (11:56) Healthcare Spending and Health Outcomes
• (14:51) The Obesity Crisis in America
• (18:01) Environmental Health Determinants
• (22:54) EU vs. US Healthcare System: A Comparative View
• (27:06) Structural Challenges in the U.S. Healthcare System
• (31:58) Value-Based Care: Insights & Limitations
• (40:41) Why State-Level Policy Variations Matter

Key Takeaways:

• The academic funding crisis threatens long-term innovation in public health education and healthcare research.
• Nutrition research and environmental health studies remain critically underfunded.
• The U.S. prioritizes reactive care over preventive population health initiatives.
• Obesity and environmental factors drive poor health outcomes.
• State-level experimentation could be a catalyst for nationwide policy change.
• Despite challenges, opportunities exist to refocus research investment on health equity, health system innovation, and population-level outcomes.

linkedin.com/in/john-mcdonough-2bb49825

linkedin.com/in/roy-bejarano-a5669ba8

www.scale-community.com

About the Guest:

John McDonough is a renowned health policy expert and Harvard professor whose work has shaped U.S. healthcare reform, including key roles in the Affordable Care Act. With decades of experience in government, academia, and advocacy, he brings unmatched insight into health systems, policy analysis, and public health—making him a leading voice in the national healthcare conversation.

Keywords

Harvard TH Chan, Public Health, Nutrition, Healthcare Policy, Population Health, Obesity, Environmental Health, Research Funding, Health Outcomes, Healthcare Spending, Healthcare Systems, Europe, US Healthcare, Value-Based Care, State Policy, Healthcare Outcomes, Investment, Patient Care, Medical Care, Population Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

In this episode, Dr. David Jacofsky, founder and CEO of HOPCo, discusses how the company is transforming musculoskeletal care through value-based models, tech-driven services, and integrated operations. He shares insights on preventative care, global risk, custom EMRs, analytics, and HOPCo’s support for practices across 34 states. The conversation also covers partnerships, tech strategy, governance, and global expansion plans.

Title: Integrating Data and Care to Lead MSK Transformation with David Jacofsky, CEO at HOPCo.

Key Timestamps:

• (00:00) Introduction to Hopco and Its Mission
• (02:53) Understanding Hopco's Business Model and Growth
• (05:47) Achieving Better Outcomes in Value-Based Care
• (08:59) Preventative Care and Comprehensive Services
• (12:01) Global Risk Management in Orthopedic Care
• (14:50) Operational Programs and Infrastructure Investments
• (18:08) Market Transformation and Integration in Healthcare
• (21:00) Service Line Offerings and Management Strategies
• (23:57) The Future of Orthopedic Care and Industry Trends
• (25:04) Building Value in Healthcare Partnerships
• (28:39) Navigating Market Entry Strategies
• (29:08) Technology Strategy: Build vs. Buy
• (34:43) Governance and Long-Term Vision
• (39:38) Strategic Partnerships in Value-Based Care
• (43:23) Direct Relationships with Employers
• (46:35) Future of Hopco and the MSK Market
• (49:21) Global Expansion Opportunities

Key Takeaways:

• HOPCo is the only fully integrated musculoskeletal platform leading orthopedic care transformation in the U.S.
• Built on four pillars: physician practice management, hospital partnerships, value-based care, and digital health.

• Its fast-growing digital division enhances patient engagement and care delivery.

• Focused on improving health outcomes and financial performance through value-based care.
• Emphasizes preventative care to lower costs and avoid unnecessary procedures.
• Takes on global risk and per-member, per-month models for long-term sustainability.
• Offers tech-driven services to boost efficiency and reduce admin burden.
• Developing a unified platform for better patient engagement and care coordination.
• Integrates services across providers to ensure continuity and market improvement.
• A model for non-MSO specialty practices looking to consolidate and scale.
• Prioritizes delivering more value than it consumes to strengthen partnerships.
• Proven track record makes HOPCo a trusted partner in value-based care.
• Grows through strategic partnerships with providers, payers, and employers.
• Uses flexible entry models that scale through deeper integration.
• Tech-forward from the start, with robust infrastructure supporting growth.
• Pursues acquisitions aligned with long-term goals and seamless integration.
• Offers a full suite of tools to improve practice efficiency and care quality.
• Partners with risk-bearing organizations to excel in population health models.
• Exploring international markets to expand its orthopedic care platform.

linkedin.com/in/david-jacofsky-md-4204419

linkedin.com/in/jasonschifman

www.scale-community.com

About the Guest:

David Jacofsky is the founder and CEO of HOPCo and The CORE Institute. A pioneer in value-based musculoskeletal care, he has grown HOPCo into a $1B national platform across 34 states. With 30+ patents and 85+ publications, his innovations have reshaped orthopedic care in the U.S.

Keywords:

#ValueBasedCare #HealthcareOperations #TechEnabledHealthcare #HealthTech #DavidJacofsky #HOPCo #MedicalPracticeSupport #HealthcareInnovation #RevenueCycleManagement #CustomEMR #HealthcareAnalytics #PracticeEfficiency #HealthcareTransformation #OutsourcedHealthcare #MSOvsNonMSO #CloudHealthcare #DigitalHealthSolutions #OrthopedicLeadership #HealthcareIT #HealthSystemPerformance #SpecialtyCareTransformation #GroupPurchasingOrganization #PhysicianGroupEfficiency

In this episode, Dr. David Jacofsky, founder and CEO of HOPCo, discusses how the company is transforming musculoskeletal care through value-based models, tech-driven services, and integrated operations. He shares insights on preventative care, global risk, custom EMRs, analytics, and HOPCo’s support for practices across 34 states. The conversation also covers partnerships, tech strategy, governance, and global expansion plans.

Title: Integrating Data and Care to Lead MSK Transformation with David Jacofsky, CEO at HOPCo

Key Timestamps:

• (00:00) Introduction to Hopco and Its Mission
• (02:53) Understanding Hopco's Business Model and Growth
• (05:47) Achieving Better Outcomes in Value-Based Care
• (08:59) Preventative Care and Comprehensive Services
• (12:01) Global Risk Management in Orthopedic Care
• (14:50) Operational Programs and Infrastructure Investments
• (18:08) Market Transformation and Integration in Healthcare
• (21:00) Service Line Offerings and Management Strategies
• (23:57) The Future of Orthopedic Care and Industry Trends
• (25:04) Building Value in Healthcare Partnerships
• (28:39) Navigating Market Entry Strategies
• (29:08) Technology Strategy: Build vs. Buy
• (34:43) Governance and Long-Term Vision
• (39:38) Strategic Partnerships in Value-Based Care
• (43:23) Direct Relationships with Employers
• (46:35) Future of Hopco and the MSK Market
• (49:21) Global Expansion Opportunities

Key Takeaways:

• HOPCo is the only fully integrated musculoskeletal platform leading orthopedic care transformation in the U.S.
• Built on four pillars: physician practice management, hospital partnerships, value-based care, and digital health.
• Its fast-growing digital division enhances patient engagement and care delivery.
• Focused on improving health outcomes and financial performance through value-based care.
• Emphasizes preventative care to lower costs and avoid unnecessary procedures.
• Takes on global risk and per-member, per-month models for long-term sustainability.
• Offers tech-driven services to boost efficiency and reduce admin burden.
• Developing a unified platform for better patient engagement and care coordination.
• Integrates services across providers to ensure continuity and market improvement.
• A model for non-MSO specialty practices looking to consolidate and scale.
• Prioritizes delivering more value than it consumes to strengthen partnerships.
• Proven track record makes HOPCo a trusted partner in value-based care.
• Grows through strategic partnerships with providers, payers, and employers.
• Uses flexible entry models that scale through deeper integration.
• Tech-forward from the start, with robust infrastructure supporting growth.
• Pursues acquisitions aligned with long-term goals and seamless integration.
• Offers a full suite of tools to improve practice efficiency and care quality.
• Partners with risk-bearing organizations to excel in population health models.
• Exploring international markets to expand its orthopedic care platform.

⁠linkedin.com/in/david-jacofsky-md-4204419⁠

⁠linkedin.com/in/jasonschifman⁠

⁠www.scale-community.com ⁠

About the Guest:

David Jacofsky is the founder and CEO of HOPCo and The CORE Institute. A pioneer in value-based musculoskeletal care, he has grown HOPCo into a $1B national platform across 34 states. With 30+ patents and 85+ publications, his innovations have reshaped orthopedic care in the U.S.

Keywords:

#ValueBasedCare #HealthcareOperations #TechEnabledHealthcare #HealthTech #DavidJacofsky #HOPCo #MedicalPracticeSupport #HealthcareInnovation #RevenueCycleManagement #CustomEMR #HealthcareAnalytics #PracticeEfficiency #HealthcareTransformation #OutsourcedHealthcare #MSOvsNonMSO #CloudHealthcare #DigitalHealthSolutions #OrthopedicLeadership #HealthcareIT #HealthSystemPerformance #SpecialtyCareTransformation #GroupPurchasingOrganization #PhysicianGroupEfficiency

In this episode, Ty Wang, CEO of Angle Health, joins Jason Schifman to share how their AI-native health plan is transforming healthcare marketing solutions for small and mid-sized businesses (SMBs). Discover how tech-driven healthcare lead generation, C-level healthcare engagement, and risk management innovations are shaping the future of healthcare access. A must-listen for those in MSO marketing strategy, healthcare sponsorship opportunities, and healthcare conferences 2025.

Title: How Angle Health Is Redefining Healthcare Marketing Solutions for SMBs | Featuring CEO Ty Wang

Key Timestamps:

• (00:00) – Introduction to Angle Health and Its Mission
• (03:02) – Focus on Small and Medium-Sized Businesses
• (06:04) – Angle Health's Unique Value Proposition
• (08:49) – Navigating Healthcare Costs and Employee Experience
• (11:56) – Operational Efficiency and Technology Integration
• (14:51) – Strategic Partnerships and Service Offerings
• (18:01) – Addressing the Needs of SMBs
• (21:02) – Customization and Plan Design Flexibility
• (23:53) – Risk Management and Underwriting Practices
• (26:49) – Future Outlook for Angle Health
• (30:03) – Market Trends and Disruptors in Healthcare

Key Takeaways:

• Angle Health delivers full-service, AI-powered health plans tailored for SMBs.
• The company champions healthcare sponsorship opportunities and healthcare brand awareness through digital-first solutions.
• Focuses on improving care through healthcare advertising platforms and tech-integrated operations.
• Offers plan customization and robust risk management practices.
• Builds strategic partnerships that support medical group marketing and physician group branding.
• Poised for growth amid shifts toward alternative funding models and healthcare innovation events.

About the Guest:

Ty Wang is the Co-Founder and CEO of Angle Health, a digital-first health insurance company focused on modernizing access to healthcare for small and mid-sized businesses. With a background in engineering and data strategy, he brings a tech-driven approach to streamlining insurance, improving care delivery, and addressing gaps in affordability, access, and patient experience across the U.S. healthcare system.

linkedin.com/in/tyw

linkedin.com/in/jasonschifman

Keywords:

Healthcare, Angle Health, AI, Small Businesses, Insurance, Employee Benefits, Cost Savings, Healthcare Services, Market Trends, Technology Integration, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Ty Wang, CEO of Angle Health, joins Jason Schifman to share how their AI-native health plan is transforming healthcare marketing solutions for small and mid-sized businesses (SMBs). Discover how tech-driven healthcare lead generation, C-level healthcare engagement, and risk management innovations are shaping the future of healthcare access. A must-listen for those in MSO marketing strategy, healthcare sponsorship opportunities, and healthcare conferences 2025.

Title: How Angle Health Is Redefining Healthcare Marketing Solutions for SMBs | Featuring CEO Ty Wang

Key Timestamps:

• (00:00) – Introduction to Angle Health and Its Mission
• (03:02) – Focus on Small and Medium-Sized Businesses
• (06:04) – Angle Health's Unique Value Proposition
• (08:49) – Navigating Healthcare Costs and Employee Experience
• (11:56) – Operational Efficiency and Technology Integration
• (14:51) – Strategic Partnerships and Service Offerings
• (18:01) – Addressing the Needs of SMBs
• (21:02) – Customization and Plan Design Flexibility
• (23:53) – Risk Management and Underwriting Practices
• (26:49} – Future Outlook for Angle Health
• (30:03} – Market Trends and Disruptors in Healthcare

Key Takeaways:

• Angle Health delivers full-service, AI-powered health plans tailored for SMBs.
• The company champions healthcare sponsorship opportunities and healthcare brand awareness through digital-first solutions.
• Focuses on improving care through healthcare advertising platforms and tech-integrated operations.
• Offers plan customization and robust risk management practices.
• Builds strategic partnerships that support medical group marketing and physician group branding.
• Poised for growth amid shifts toward alternative funding models and healthcare innovation events.

About the Guest:

Ty Wang is the Co-Founder and CEO of Angle Health, a digital-first health insurance company focused on modernizing access to healthcare for small and mid-sized businesses. With a background in engineering and data strategy, he brings a tech-driven approach to streamlining insurance, improving care delivery, and addressing gaps in affordability, access, and patient experience across the U.S. healthcare system.

linkedin.com/in/tyw

linkedin.com/in/jasonschifman

Keywords:

Healthcare, Angle Health, AI, Small Businesses, Insurance, Employee Benefits, Cost Savings, Healthcare Services, Market Trends, Technology Integration, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

In this episode, Jason Schifman interviews Michael Liebman, co-founder of IPQ Analytics, to discuss the importance of understanding diseases, particularly in women's health. They explore the flaws in current medical approaches, the need for a holistic view of health conditions, and the role of data analytics in improving patient outcomes. Michael shares insights on various women's health issues, including breast cancer, maternal health, and menopause, and emphasizes the importance of collaboration in healthcare research.

Title: The Hidden Data Gaps Crippling Healthcare Innovation – with Michael Liebman, Co-founder of IPQ Analytic

Key Timestamps:

• (00:00) Introduction to IPQ Analytics and Michael Liebman
• (04:01) Understanding Disease: The Flaws in Current Approaches
• (11:50) Exploring Women's Health: Conditions and Challenges
• (17:56) Data Collection and Analysis: The Role of IPQ Analytics
• (23:49) The Journey of Women: From Menarche to Menopause
• (30:00) International Perspectives on Healthcare Data
• (36:05) Collaborative Approaches in Healthcare Research

Key Takeaways:

• IPQ Analytics focuses on understanding diseases from multiple perspectives.
• Current medical practices often lack a holistic view of health conditions.
• There is a need to move from correlation to causality in healthcare research.
• Women's health issues, such as menopause, require more comprehensive data.
• The age of menarche is decreasing, impacting women's health.
• Collaboration with international healthcare networks is essential for data collection.
• The Nordic countries excel in healthcare data collection and organization.
• Clinicians need better tools to ask the right questions about patient health.
• Understanding the journey of women from menarche to menopause is crucial for personalized medicine.
• Healthcare innovation should focus on problem-solving rather than just technology application.

⁠linkedin.com/in/michael-n-liebman-4b55b25 ⁠

⁠linkedin.com/in/jasonschifman⁠

⁠www.scale-community.com ⁠

About the Guest:

Michael Liebman is a renowned biomedical scientist and thought leader in healthcare innovation. He is the Executive Director of IPQ Analytics and has pioneered approaches in disease understanding, personalized medicine, and data-driven healthcare. With a focus on women’s health and system-level change, his work bridges clinical research and real-world outcomes to drive more effective, patient-centered care.

Keywords:

Ipq Analytics, Women's Health, Breast Cancer, Data Analytics, Healthcare Innovation, Disease Understanding, Preventative Care, Clinical Research, Healthcare Collaboration, Patient Outcomes, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

In this episode, Jason Schifman interviews Michael Liebman, co-founder of IPQ Analytics, to discuss the importance of understanding diseases, particularly in women's health. They explore the flaws in current medical approaches, the need for a holistic view of health conditions, and the role of data analytics in improving patient outcomes. Michael shares insights on various women's health issues, including breast cancer, maternal health, and menopause, and emphasizes the importance of collaboration in healthcare research.

Title: The Hidden Data Gaps Crippling Healthcare Innovation – with Michael Liebman, Co-founder of IPQ Analytic

Key Timestamps:

• (00:00) Introduction to IPQ Analytics and Michael Liebman
• (04:01) Understanding Disease: The Flaws in Current Approaches
• (11:50) Exploring Women's Health: Conditions and Challenges
• (17:56) Data Collection and Analysis: The Role of IPQ Analytics
• (23:49) The Journey of Women: From Menarche to Menopause
• (30:00) International Perspectives on Healthcare Data
• (36:05) Collaborative Approaches in Healthcare Research

Key Takeaways:

• IPQ Analytics focuses on understanding diseases from multiple perspectives.
• Current medical practices often lack a holistic view of health conditions.
• There is a need to move from correlation to causality in healthcare research.
• Women's health issues, such as menopause, require more comprehensive data.
• The age of menarche is decreasing, impacting women's health.
• Collaboration with international healthcare networks is essential for data collection.
• The Nordic countries excel in healthcare data collection and organization.
• Clinicians need better tools to ask the right questions about patient health.
• Understanding the journey of women from menarche to menopause is crucial for personalized medicine.
• Healthcare innovation should focus on problem-solving rather than just technology application.

linkedin.com/in/michael-n-liebman-4b55b25

linkedin.com/in/jasonschifman

www.scale-community.com

About the Guest:

Michael Liebman is a renowned biomedical scientist and thought leader in healthcare innovation. He is the Executive Director of IPQ Analytics and has pioneered approaches in disease understanding, personalized medicine, and data-driven healthcare. With a focus on women’s health and system-level change, his work bridges clinical research and real-world outcomes to drive more effective, patient-centered care.

Keywords:

Ipq Analytics, Women's Health, Breast Cancer, Data Analytics, Healthcare Innovation, Disease Understanding, Preventative Care, Clinical Research, Healthcare Collaboration, Patient Outcomes, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

In this episode of Analyzing Healthcare, Dr. Meena Seshamani, director of the Center for Medicare, discusses managing Medicare and Medicaid complexities in US Healthcare, initiatives to improve patient care, and the importance of transparency and engagement in healthcare policy. She elaborates on care transformation, Medicare Advantage challenges, and significant prescription drug pricing changes, emphasizing teamwork and collaboration. Dr. Meena Seshamani and Roy Bejarano discuss the complexities of drug pricing in America, Medicare's role in negotiating drug prices, and the impact of pharmacy benefit managers on healthcare costs. They explore the need for transparency in drug pricing and the potential benefits of new market entrants. The discussion also highlights state-level healthcare innovations, particularly Maryland's unique payment model, and the importance of focusing on prevention and chronic disease management. Meena shares her vision for the future of healthcare in Maryland, emphasizing a system that cares for individuals throughout their lives.

Title: She Transformed Medicare for 68 Million Americans—Now She Reveals What’s Next: A Discussion with Former Medicare Director, Dr. Meena Seshamani

Key Timestamps:

• (00:00) Introduction To Medicare Leadership
• (03:02) Understanding Medicare And Medicaid
• (06:10) Transforming Care In Medicare
• (09:06) Medicare Advantage And Transparency
• (12:00) Prescription Drug Affordability Initiatives
• (15:02) Engagement And Team Dynamics In Medicare
• (18:01) Comparing Medicare With Other Payers
• (20:46) Pricing Mechanisms In Medicare
• (28:24) The Story Of Drug Pricing In America
• (32:01) Medicare's Role In Drug Negotiation
• (37:03) The Impact Of Drug Pricing On Healthcare Costs
• (40:27) New Entrants In The Drug Market
• (47:38) State-Level Innovations In Healthcare
• (54:06) Future Goals For Maryland's Health System

Key Takeaways:

• Medicare serves 68M+ Americans (65+), a federal program unlike state-run Medicaid.
• Transforming care integrates behavioral health and community services.
• Medicare Advantage needs transparency and better navigation.
• The Inflation Reduction Act changed Medicare drug pricing.
• Stakeholder engagement is key for policy.
• Medicare pricing is statutory and budget-neutral.
• The Medicare Shared Savings Program promotes value-based care.
• Auditing and oversight are essential.
• Collaboration enhances Medicare effectiveness.
• US drug pricing is complex.
• Pharmacy Benefit Managers (PBMs) significantly control drug purchasing.
• Medicare negotiation can yield major savings.
• Drug pricing transparency is vital for trust.
• Healthcare markets differ from traditional ones.
• State-level innovations can model reform.
• Maryland's payment model enables healthcare innovation.
• Preventative care improves health outcomes.
• Life expectancy needs context.
• A holistic healthcare approach is necessary.

linkedin.com/in/meena-seshamani-0679424

linkedin.com/in/roy-bejarano-a5669ba8

www.scale-community.com

About the Guest:

Dr. Meena Seshamani, former Director of the Center for Medicare at CMS, led transformative efforts in U.S. healthcare. A physician and health economist, she championed equitable access, prescription drug affordability, Medicare Advantage transparency, and community-based care. Her leadership helped implement the Inflation Reduction Act and drove Medicare’s shift toward value-based, patient-centered models, impacting over 68 million Americans.

Keywords:

Medicare, Medicaid, Healthcare, Prescription Drugs, Medicare Advantage, Healthcare Policy, Health Equity, Pricing, Healthcare Transformation, Patient Care, Drug Pricing, Medicare, Healthcare Costs, Pharmacy Benefit Managers, Health Economics, Drug Negotiation, Healthcare Innovation, Maryland Health System, Healthcare Transparency, Prescription Drugs, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

In this episode of Analyzing Healthcare, Dr. Meena Seshamani, director of the Center for Medicare, discusses managing Medicare and Medicaid complexities in US Healthcare, initiatives to improve patient care, and the importance of transparency and engagement in healthcare policy. She elaborates on care transformation, Medicare Advantage challenges, and significant prescription drug pricing changes, emphasizing teamwork and collaboration. Dr. Meena Seshamani and Roy Bejarano discuss the complexities of drug pricing in America, Medicare's role in negotiating drug prices, and the impact of pharmacy benefit managers on healthcare costs. They explore the need for transparency in drug pricing and the potential benefits of new market entrants. The discussion also highlights state-level healthcare innovations, particularly Maryland's unique payment model, and the importance of focusing on prevention and chronic disease management. Meena shares her vision for the future of healthcare in Maryland, emphasizing a system that cares for individuals throughout their lives.

Title: She Transformed Medicare for 68 Million Americans—Now She Reveals What’s Next: A Discussion with Former Medicare Director, Dr. Meena Seshamani

Key Timestamps:

• (00:00) Introduction To Medicare Leadership
• (03:02) Understanding Medicare And Medicaid
• (06:10) Transforming Care In Medicare
• (09:06) Medicare Advantage And Transparency
• (12:00) Prescription Drug Affordability Initiatives
• (15:02) Engagement And Team Dynamics In Medicare
• (18:01) Comparing Medicare With Other Payers
• (20:46) Pricing Mechanisms In Medicare
• (28:24) The Story Of Drug Pricing In America
• (32:01) Medicare's Role In Drug Negotiation
• (37:03) The Impact Of Drug Pricing On Healthcare Costs
• (40:27) New Entrants In The Drug Market
• (47:38) State-Level Innovations In Healthcare
• (54:06) Future Goals For Maryland's Health System

Key Takeaways:

• Medicare serves 68M+ Americans (65+), a federal program unlike state-run Medicaid.
• Transforming care integrates behavioral health and community services.
• Medicare Advantage needs transparency and better navigation.
• The Inflation Reduction Act changed Medicare drug pricing.
• Stakeholder engagement is key for policy.
• Medicare pricing is statutory and budget-neutral.
• The Medicare Shared Savings Program promotes value-based care.
• Auditing and oversight are essential.
• Collaboration enhances Medicare effectiveness.
• US drug pricing is complex.
• Pharmacy Benefit Managers (PBMs) significantly control drug purchasing.
• Medicare negotiation can yield major savings.
• Drug pricing transparency is vital for trust.
• Healthcare markets differ from traditional ones.
• State-level innovations can model reform.
• Maryland's payment model enables healthcare innovation.
• Preventative care improves health outcomes.
• Life expectancy needs context.
• A holistic healthcare approach is necessary.

⁠linkedin.com/in/meena-seshamani-0679424 ⁠

⁠linkedin.com/in/roy-bejarano-a5669ba8⁠

⁠www.scale-community.com ⁠

About the Guest:

Dr. Meena Seshamani, former Director of the Center for Medicare at CMS, led transformative efforts in U.S. healthcare. A physician and health economist, she championed equitable access, prescription drug affordability, Medicare Advantage transparency, and community-based care. Her leadership helped implement the Inflation Reduction Act and drove Medicare’s shift toward value-based, patient-centered models, impacting over 68 million Americans.

Keywords:

Medicare, Medicaid, Healthcare, Prescription Drugs, Medicare Advantage, Healthcare Policy, Health Equity, Pricing, Healthcare Transformation, Patient Care, Drug Pricing, Medicare, Healthcare Costs, Pharmacy Benefit Managers, Health Economics, Drug Negotiation, Healthcare Innovation, Maryland Health System, Healthcare Transparency, Prescription Drugs, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends